Product Data Sheet

RIPK1-IN-34

Catalog No. A25248

main product photo
RIPK1-IN-34 is a selective inhibitor of receptor-interacting protein kinase 1 (RIPK1) with an IC50 of 126.70 nM, demonstrating significant potency and minimal off-target effects on RIPK3 (IC50 > 10,000 nM). This compound provides substantial neuroprotection by preventing the phosphorylation of key proteins involved in the necroptosis pathway, including RIPK1, RIPK3, and MLKL. Notably, RIPK1-IN-34 exhibits neuroprotective effects in the rat middle cerebral artery occlusion (MCAO) model, making it a valuable tool for research focused on mitigating damage in acute ischemic stroke (AIS).
Chemical Information
Catalog NumA25248
M. Wt491.54
FormulaC28H25N7O2
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.3065634-19-4
Synonyms
SMILESO=C(C1=C2C=C(C3=CC4=NC(NC(C5CC5)=O)=NN4C=C3)C=CC2=NC(C)=N1)N[C@H](C6=CC=CC=C6)C
Biological Activity
DescriptionRIPK1-IN-34 is a selective inhibitor of receptor-interacting protein kinase 1 (RIPK1) with an IC50 of 126.70 nM, demonstrating significant potency and minimal off-target effects on RIPK3 (IC50 > 10,000 nM). This compound provides substantial neuroprotection by preventing the phosphorylation of key proteins involved in the necroptosis pathway, including RIPK1, RIPK3, and MLKL. Notably, RIPK1-IN-34 exhibits neuroprotective effects in the rat middle cerebral artery occlusion (MCAO) model, making it a valuable tool for research focused on mitigating damage in acute ischemic stroke (AIS).
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.